|
IRADIMED CORPORATION (IRMD) Avaliação DCF
US | Healthcare | Medical - Devices | NASDAQ
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
IRadimed Corporation (IRMD) Bundle
Aprimore suas opções de investimento com a calculadora DCF da IRADIMED CORPORATION (IRMD)! Revise as finanças autênticas da Apple, ajustam as projeções e despesas de crescimento e observe instantaneamente como essas mudanças afetam o valor intrínseco da IRADIMED CORPORATION (IRMD).
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 38.5 | 31.7 | 41.8 | 53.3 | 65.6 | 76.2 | 88.5 | 102.8 | 119.4 | 138.7 |
| Revenue Growth, % | 0 | -17.65 | 31.83 | 27.48 | 23 | 16.16 | 16.16 | 16.16 | 16.16 | 16.16 |
| EBITDA | 9.9 | .6 | 11.2 | 16.3 | 20.8 | 17.8 | 20.6 | 24.0 | 27.9 | 32.4 |
| EBITDA, % | 25.68 | 1.84 | 26.84 | 30.58 | 31.73 | 23.33 | 23.33 | 23.33 | 23.33 | 23.33 |
| Depreciation | .6 | .6 | .6 | .7 | .8 | 1.1 | 1.3 | 1.5 | 1.8 | 2.0 |
| Depreciation, % | 1.53 | 1.9 | 1.52 | 1.26 | 1.17 | 1.48 | 1.48 | 1.48 | 1.48 | 1.48 |
| EBIT | 9.3 | .0 | 10.6 | 15.6 | 20.0 | 16.6 | 19.3 | 22.5 | 26.1 | 30.3 |
| EBIT, % | 24.14 | -0.06578099 | 25.33 | 29.32 | 30.56 | 21.86 | 21.86 | 21.86 | 21.86 | 21.86 |
| Total Cash | 46.3 | 52.0 | 62.5 | 58.0 | 49.8 | 72.5 | 84.2 | 97.8 | 113.6 | 132.0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 7.3 | 4.6 | 5.1 | 13.3 | 12.2 | 13.6 | 15.8 | 18.3 | 21.3 | 24.7 |
| Account Receivables, % | 18.94 | 14.42 | 12.28 | 24.9 | 18.65 | 17.84 | 17.84 | 17.84 | 17.84 | 17.84 |
| Inventories | 3.6 | 3.9 | 4.3 | 5.4 | 12.8 | 9.4 | 10.9 | 12.7 | 14.7 | 17.1 |
| Inventories, % | 9.45 | 12.4 | 10.28 | 10.07 | 19.56 | 12.35 | 12.35 | 12.35 | 12.35 | 12.35 |
| Accounts Payable | 1.0 | .7 | .8 | 1.8 | 1.9 | 1.9 | 2.3 | 2.6 | 3.0 | 3.5 |
| Accounts Payable, % | 2.58 | 2.07 | 1.87 | 3.38 | 2.83 | 2.55 | 2.55 | 2.55 | 2.55 | 2.55 |
| Capital Expenditure | -.5 | -.6 | -.7 | -1.9 | -8.0 | -3.2 | -3.7 | -4.3 | -5.0 | -5.8 |
| Capital Expenditure, % | -1.26 | -2.01 | -1.77 | -3.52 | -12.21 | -4.15 | -4.15 | -4.15 | -4.15 | -4.15 |
| Tax Rate, % | 20.91 | 20.91 | 20.91 | 20.91 | 20.91 | 20.91 | 20.91 | 20.91 | 20.91 | 20.91 |
| EBITAT | 9.9 | .0 | 10.0 | 12.4 | 15.8 | 11.8 | 13.7 | 15.9 | 18.4 | 21.4 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | .1 | 2.1 | 9.1 | 3.0 | 2.3 | 11.9 | 7.9 | 9.2 | 10.6 | 12.4 |
| WACC, % | 8.21 | 8.2 | 8.21 | 8.21 | 8.21 | 8.21 | 8.21 | 8.21 | 8.21 | 8.21 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 41.0 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 13 | |||||||||
| Terminal Value | 306 | |||||||||
| Present Terminal Value | 206 | |||||||||
| Enterprise Value | 247 | |||||||||
| Net Debt | -48 | |||||||||
| Equity Value | 295 | |||||||||
| Diluted Shares Outstanding, MM | 13 | |||||||||
| Equity Value Per Share | 23.17 |
What You Will Receive
- Customizable Excel Template: A fully adjustable Excel-based DCF Calculator featuring pre-entered real IRMD financials.
- Authentic Data: Historical figures and future projections (highlighted in the yellow cells).
- Flexible Forecasting: Adjust forecast variables such as revenue growth, EBITDA %, and WACC.
- Instant Calculations: Quickly observe how your inputs affect IRadimed’s valuation.
- Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
- User-Centric Layout: Organized for clarity and simplicity, complete with step-by-step guidance.
Key Features
- Comprehensive DCF Calculator: Offers detailed unlevered and levered DCF valuation models tailored for IRadimed Corporation (IRMD).
- WACC Calculator: Features a pre-built Weighted Average Cost of Capital sheet with adjustable inputs specifically for IRMD.
- Customizable Forecast Assumptions: Easily modify growth rates, capital expenditures, and discount rates relevant to IRadimed Corporation (IRMD).
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios pertinent to IRadimed Corporation (IRMD).
- Interactive Dashboard and Charts: Visual representations summarize essential valuation metrics for straightforward analysis of IRadimed Corporation (IRMD).
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered IRadimed Corporation (IRMD) data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for IRadimed Corporation’s intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose This Calculator for IRadimed Corporation (IRMD)?
- Designed for Industry Experts: A sophisticated tool tailored for analysts, CFOs, and healthcare consultants.
- Up-to-Date Financial Data: IRadimed's historical and projected financials are preloaded for precision.
- Flexible Scenario Analysis: Effortlessly test various forecasts and assumptions.
- Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
- User-Friendly Interface: Step-by-step guidance ensures a smooth calculation process.
Who Should Use IRadimed Corporation (IRMD) Products?
- Healthcare Providers: Enhance patient care with advanced MRI-compatible infusion systems.
- Biomedical Engineers: Utilize cutting-edge technology to innovate and improve medical devices.
- Medical Consultants: Tailor solutions for clients in the healthcare sector with ease.
- Investors: Analyze the potential of a growing company in the medical device market.
- Students and Educators: Explore real-world applications of medical technology in academic settings.
What the Template Contains
- Comprehensive DCF Model: Editable template with detailed valuation calculations for IRadimed Corporation (IRMD).
- Real-World Data: IRadimed’s historical and projected financials preloaded for analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to test scenarios specific to IRMD.
- Financial Statements: Full annual and quarterly breakdowns for deeper insights into IRadimed's performance.
- Key Ratios: Built-in analysis for profitability, efficiency, and leverage tailored to IRMD.
- Dashboard with Visual Outputs: Charts and tables for clear, actionable results regarding IRadimed Corporation (IRMD).
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.